Nuveen’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.91B | Sell |
5,337,672
-96,900
| -2% | -$98.2M | 1.33% | 10 |
|
|
2025
Q4 | $5.84B | Buy |
5,434,572
+17,796
| +0.3% | +$17M | 1.53% | 10 |
|
|
2025
Q3 | $4.13B | Sell |
5,416,776
-272,957
| -5% | -$203M | 1.09% | 12 |
|
|
2025
Q2 | $4.44B | Buy |
5,689,733
+103,274
| +2% | +$80.3M | 1.23% | 10 |
|
|
2025
Q1 | $4.61B | Buy |
5,586,459
+383,064
| +7% | +$319M | 1.4% | 7 |
|
|
2024
Q4 | $4.02B | Buy |
5,203,395
+135,889
| +3% | +$113M | 1.13% | 10 |
|
|
2024
Q3 | $4.49B | Sell |
5,067,506
-87,877
| -2% | -$79M | 1.26% | 9 |
|
|
2024
Q2 | $4.67B | Sell |
5,155,383
-129,843
| -2% | -$104M | 1.36% | 9 |
|
|
2024
Q1 | $4.11B | Sell |
5,285,226
-78,720
| -1% | -$56M | 1.22% | 9 |
|
|
2023
Q4 | $3.13B | Buy |
5,363,946
+89,168
| +2% | +$52M | 1.01% | 12 |
|
|
2023
Q3 | $2.83B | Buy |
5,274,778
+174,753
| +3% | +$90M | 1% | 12 |
|
|
2023
Q2 | $2.39B | Sell |
5,100,025
-59,378
| -1% | -$24.9M | 0.83% | 15 |
|
|
2023
Q1 | $1.77B | Buy |
5,159,403
+123,239
| +2% | +$41.6M | 0.66% | 24 |
|
|
2022
Q4 | $1.84B | Sell |
5,036,164
-98,034
| -2% | -$34.8M | 0.71% | 23 |
|
|
2022
Q3 | $1.66B | Sell |
5,134,198
-44,141
| -0.9% | -$14M | 0.67% | 21 |
|
|
2022
Q2 | $1.68B | Buy |
5,178,339
+99,705
| +2% | +$29.9M | 0.65% | 22 |
|
|
2022
Q1 | $1.47B | Buy |
5,078,634
+636,694
| +14% | +$164M | 0.48% | 36 |
|
|
2021
Q4 | $1.23B | Sell |
4,441,940
-135,923
| -3% | -$34.5M | 0.36% | 49 |
|
|
2021
Q3 | $1.06B | Sell |
4,577,863
-507,035
| -10% | -$125M | 0.33% | 57 |
|
|
2021
Q2 | $1.17B | Sell |
5,084,898
-249,534
| -5% | -$50.1M | 0.35% | 49 |
|
|
2021
Q1 | $997M | Sell |
5,334,432
-1,198,133
| -18% | -$234M | 0.32% | 61 |
|
|
2020
Q4 | $1.1B | Sell |
6,532,565
-1,330,664
| -17% | -$199M | 0.37% | 51 |
|
|
2020
Q3 | $1.16B | Sell |
7,863,229
-163,638
| -2% | -$25.3M | 0.45% | 44 |
|
|
2020
Q2 | $1.32B | Buy |
8,026,867
+2,372,251
| +42% | +$364M | 0.54% | 27 |
|
|
2020
Q1 | $784M | Buy |
5,654,616
+1,533,024
| +37% | +$211M | 0.38% | 54 |
|
|
2019
Q4 | $542M | Sell |
4,121,592
-2,740,499
| -40% | -$318M | 0.21% | 106 |
|
|
2019
Q3 | $767M | Sell |
6,862,091
-403,753
| -6% | -$45M | 0.31% | 62 |
|
|
2019
Q2 | $805M | Buy |
7,265,844
+7,229,751
| +20,031% | +$851M | 0.32% | 57 |
|
|
2019
Q1 | $4.68M | Sell |
36,093
-321
| -0.9% | -$39K | 0.03% | 517 |
|
|
2018
Q4 | $4.21M | Sell |
36,414
-294
| -0.8% | -$32.8K | 0.03% | 510 |
|
|
2018
Q3 | $3.94M | Sell |
36,708
-719
| -2% | -$71.9K | 0.02% | 541 |
|
|
2018
Q2 | $3.19M | Buy |
37,427
+285
| +0.8% | +$23.4K | 0.02% | 538 |
|
|
2018
Q1 | $2.87M | Sell |
37,142
-14
| -0% | -$1.13K | 0.02% | 552 |
|
|
2017
Q4 | $3.14M | Sell |
37,156
-329
| -0.9% | -$28K | 0.02% | 525 |
|
|
2017
Q3 | $3.21M | Buy |
37,485
+63
| +0.2% | +$5.17K | 0.02% | 545 |
|
|
2017
Q2 | $3.08M | Sell |
37,422
-25,416
| -40% | -$2.07M | 0.02% | 547 |
|
|
2017
Q1 | $5.29M | Sell |
62,838
-100,323
| -61% | -$8.04M | 0.03% | 512 |
|
|
2016
Q4 | $12M | Buy |
163,161
+87,572
| +116% | +$6.52M | 0.06% | 400 |
|
|
2016
Q3 | $6.07M | Hold |
75,589
| – | – | 0.04% | 497 |
|
|
2016
Q2 | $5.95M | Sell |
75,589
-8,564
| -10% | -$645K | 0.04% | 459 |
|
|
2016
Q1 | $6.06K | Buy |
84,153
+3,348
| +4% | +$253K | 0.03% | 437 |
|
|
2015
Q4 | $6.81K | Sell |
80,805
-2,691
| -3% | -$223K | 0.04% | 408 |
|
|
2015
Q3 | $6.99K | Buy |
83,496
+1,625
| +2% | +$137K | 0.04% | 407 |
|
|
2015
Q2 | $6.83K | Sell |
81,871
-385
| -0.5% | -$29.3K | 0.04% | 459 |
|
|
2015
Q1 | $5.98M | Buy |
82,256
+375
| +0.5% | +$26.7K | 0.03% | 483 |
|
|
2014
Q4 | $5.65M | Buy |
81,881
+16,752
| +26% | +$1.13M | 0.03% | 516 |
|
|
2014
Q3 | $4.22M | Sell |
65,129
-17,264
| -21% | -$1.09M | 0.03% | 592 |
|
|
2014
Q2 | $5.12M | Sell |
82,393
-6,177
| -7% | -$369K | 0.03% | 551 |
|
|
2014
Q1 | $5.21M | Sell |
88,570
-1,468
| -2% | -$81.9K | 0.03% | 525 |
|
|
2013
Q4 | $4.59M | Sell |
90,038
-110,535
| -55% | -$5.54M | 0.03% | 535 |
|
|
2013
Q3 | $10.1M | Buy |
200,573
+634
| +0.3% | +$33.2K | 0.07% | 365 |
|
|
2013
Q2 | $9.82M | Buy |
+199,939
| New | +$10.9M | 0.07% | 353 |
|
Other funds holding LLY
VCM
VPM
Nuveen's LLY Position: Q1 2026 in Review
Nuveen reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $98.2M and leaving 5,337,672 shares worth $4.91B. The position accounts for 1.33% of the portfolio, ranked #10.
Nuveen first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.84B in Q4 2025. 4,360 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Nuveen held 5,337,672 shares of Eli Lilly worth $4.91B as of Q1 2026.
- Nuveen sold 96,900 Eli Lilly shares in Q1 2026, an estimated $98.2M.
- Eli Lilly made up 1.33% of Nuveen's portfolio in Q1 2026, its #10 holding.
- Nuveen first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Nuveen's Eli Lilly position peaked at $5.84B in Q4 2025.
- 4,360 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.